 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | RH5.2 VLP in Matrix-MTM / University of Oxford, RH5.2-VLP / University of Oxford
Enrollment closed, Trial completion date, Trial primary completion date: A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines (clinicaltrials.gov) - Nov 6, 2024
P1/2, N=58, Active, not recruiting, Sponsor: University of Oxford
Recruiting --> Active, not recruiting | Trial completion date: Mar 2025 --> Mar 2026 | Trial primary completion date: Mar 2025 --> Jan 2026
- | RH5.2 VLP in Matrix-MTM / University of Oxford, RH5.2-VLP / University of Oxford
Enrollment change: A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. (clinicaltrials.gov) - Oct 23, 2023
P2b, N=480, Recruiting, Sponsor: University of Oxford
Recruiting --> Active, not recruiting | Trial completion date: Mar 2025 --> Mar 2026 | Trial primary completion date: Mar 2025 --> Jan 2026 N=720 --> 480
- | RH5.2 VLP in Matrix-MTM / University of Oxford, RH5.2-VLP / University of Oxford
Enrollment open: A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines (clinicaltrials.gov) - Sep 8, 2023
P1/2, N=56, Recruiting, Sponsor: University of Oxford
N=720 --> 480 Not yet recruiting --> Recruiting
- | RH5.2 VLP in Matrix-MTM / University of Oxford, RH5.2-VLP / University of Oxford
New P1/2 trial: A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines (clinicaltrials.gov) - Aug 7, 2023
P1/2, N=56, Not yet recruiting, Sponsor: University of Oxford
- | RH5.2 VLP in Matrix-MTM / University of Oxford, RH5.2-VLP / University of Oxford, R21/Matrix-M / University of Oxford, Serum Institute of India
Enrollment open: A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21 (clinicaltrials.gov) - Jul 27, 2023
P1, N=96, Recruiting, Sponsor: University of Oxford
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | RH5.2 VLP in Matrix-MTM / University of Oxford, RH5.2-VLP / University of Oxford
Enrollment open: A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. (clinicaltrials.gov) - Apr 6, 2023
P2b, N=720, Recruiting, Sponsor: University of Oxford
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | RH5.2 VLP in Matrix-MTM / University of Oxford, RH5.2-VLP / University of Oxford
New P2b trial: A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. (clinicaltrials.gov) - Mar 30, 2023
P2b, N=720, Not yet recruiting, Sponsor: University of Oxford
- | RH5.2 VLP in Matrix-MTM / University of Oxford, RH5.2-VLP / University of Oxford, R21/Matrix-M / University of Oxford, Serum Institute of India
Trial initiation date: A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21 (clinicaltrials.gov) - Oct 24, 2022
P1, N=96, Not yet recruiting, Sponsor: University of Oxford
Not yet recruiting --> Recruiting Initiation date: Sep 2022 --> Feb 2023
- | RH5.2 VLP in Matrix-MTM / University of Oxford, RH5.2-VLP / University of Oxford, R21/Matrix-M / University of Oxford, Serum Institute of India
New P1 trial: A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21 (clinicaltrials.gov) - May 2, 2022
P1, N=96, Not yet recruiting, Sponsor: University of Oxford